カテゴリー： LP Information, 世界, 部品/材料

世界のレチガビン市場予測 2023年-2029年

◆英語タイトル：Global Retigabine Market Growth 2023-2029
	◆商品コード：LP23JU7590 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のレチガビン市場」は、過去の販売実績から2022年の世界のレチガビンの総販売量を検討し、2023年から2029年の予測されるレチガビンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のレチガビンの市場規模を掲載し、XXX百万米ドル規模の世界のレチガビン市場の詳細な分析を提供します。本インサイトレポートは、世界のレチガビン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のレチガビン市場における各社の独自のポジションをより深く理解するために、レチガビン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のレチガビン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。レチガビンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。レチガビンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。レチガビンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

レチガビンの世界主要メーカーとしては、Merck、 BioVision、 Selleck Chemicals、 Bio-Techne、 Cayman Chemical、 Adooq Bioscience、 Alomone Labs、 Toronto Research Chemicals、 BOCSCI、 Biosynth Carbosynth、 Axon Biochemicals BV、 Beyotimeなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のレチガビン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではレチガビン市場をセグメンテーションし、種類別 (最小純度98%以下、最小純度98%-99%、最小純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：最小純度98%以下、最小純度98%-99%、最小純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のレチガビン市場の10年間の市場状況・展望は？
・世界および地域別に見たレチガビン市場成長の要因は何か？
・レチガビンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・レチガビンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：レチガビンの年間販売量2018-2029、地域別現状・将来分析
・レチガビンの種類別セグメント：最小純度98%以下、最小純度98%-99%、最小純度99%以上
・レチガビンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・レチガビンの用途別セグメント：研究、医療
・レチガビンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のレチガビン市場
・企業別のグローバルレチガビン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のレチガビンの年間売上：2018-2023年の売上、市場シェア
・企業別のレチガビン販売価格
・主要企業のレチガビン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

レチガビンの地域別レビュー
・地域別のレチガビン市場規模2018-2023：年間販売量、売上
・主要国別のレチガビン市場規模2018-2023：年間販売量、売上
・南北アメリカのレチガビン販売の成長
・アジア太平洋のレチガビン販売の成長
・ヨーロッパのレチガビン販売の成長
・中東・アフリカのレチガビン販売の成長

南北アメリカ市場
・南北アメリカの国別のレチガビン販売量、売上（2018-2023）
・南北アメリカのレチガビンの種類別販売量
・南北アメリカのレチガビンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のレチガビン販売量、売上（2018-2023）
・アジア太平洋のレチガビンの種類別販売量
・アジア太平洋のレチガビンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のレチガビン販売量、売上（2018-2023）
・ヨーロッパのレチガビンの種類別販売量
・ヨーロッパのレチガビンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のレチガビン販売量、売上（2018-2023）
・中東・アフリカのレチガビンの種類別販売量
・中東・アフリカのレチガビンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・レチガビンの製造コスト構造分析
・レチガビンの製造プロセス分析
・レチガビンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・レチガビンの主要なグローバル販売業者
・レチガビンの主要なグローバル顧客

地域別のレチガビン市場予測レビュー
・地域別のレチガビン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・レチガビンの種類別市場規模予測
・レチガビンの用途別市場規模予測

主要企業分析
Merck、 BioVision、 Selleck Chemicals、 Bio-Techne、 Cayman Chemical、 Adooq Bioscience、 Alomone Labs、 Toronto Research Chemicals、 BOCSCI、 Biosynth Carbosynth、 Axon Biochemicals BV、 Beyotime
・企業情報
・レチガビン製品
・レチガビン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Retigabine is a highly pure, synthetic, and biologically active compound.
LPI (LP Information)’ newest research report, the “Retigabine Industry Forecast” looks at past sales and reviews total world Retigabine sales in 2022, providing a comprehensive analysis by region and market sector of projected Retigabine sales for 2023 through 2029. With Retigabine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retigabine industry.
This Insight Report provides a comprehensive analysis of the global Retigabine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Retigabine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retigabine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retigabine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retigabine.
The global Retigabine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Retigabine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Retigabine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Retigabine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Retigabine players cover Merck, BioVision, Selleck Chemicals, Bio-Techne, Cayman Chemical, Adooq Bioscience, Alomone Labs, Toronto Research Chemicals and BOCSCI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Retigabine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
BioVision
Selleck Chemicals
Bio-Techne
Cayman Chemical
Adooq Bioscience
Alomone Labs
Toronto Research Chemicals
BOCSCI
Biosynth Carbosynth
Axon Biochemicals BV
Beyotime
Key Questions Addressed in this Report
What is the 10-year outlook for the global Retigabine market?
What factors are driving Retigabine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Retigabine market opportunities vary by end market size?
How does Retigabine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Retigabine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Retigabine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Retigabine by Country/Region, 2018, 2022 & 2029
2.2 Retigabine Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Retigabine Sales by Type
2.3.1 Global Retigabine Sales Market Share by Type (2018-2023)
2.3.2 Global Retigabine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Retigabine Sale Price by Type (2018-2023)
2.4 Retigabine Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Retigabine Sales by Application
2.5.1 Global Retigabine Sale Market Share by Application (2018-2023)
2.5.2 Global Retigabine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Retigabine Sale Price by Application (2018-2023)
3 Global Retigabine by Company
3.1 Global Retigabine Breakdown Data by Company
3.1.1 Global Retigabine Annual Sales by Company (2018-2023)
3.1.2 Global Retigabine Sales Market Share by Company (2018-2023)
3.2 Global Retigabine Annual Revenue by Company (2018-2023)
3.2.1 Global Retigabine Revenue by Company (2018-2023)
3.2.2 Global Retigabine Revenue Market Share by Company (2018-2023)
3.3 Global Retigabine Sale Price by Company
3.4 Key Manufacturers Retigabine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Retigabine Product Location Distribution
3.4.2 Players Retigabine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Retigabine by Geographic Region
4.1 World Historic Retigabine Market Size by Geographic Region (2018-2023)
4.1.1 Global Retigabine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Retigabine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Retigabine Market Size by Country/Region (2018-2023)
4.2.1 Global Retigabine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Retigabine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Retigabine Sales Growth
4.4 APAC Retigabine Sales Growth
4.5 Europe Retigabine Sales Growth
4.6 Middle East & Africa Retigabine Sales Growth
5 Americas
5.1 Americas Retigabine Sales by Country
5.1.1 Americas Retigabine Sales by Country (2018-2023)
5.1.2 Americas Retigabine Revenue by Country (2018-2023)
5.2 Americas Retigabine Sales by Type
5.3 Americas Retigabine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Retigabine Sales by Region
6.1.1 APAC Retigabine Sales by Region (2018-2023)
6.1.2 APAC Retigabine Revenue by Region (2018-2023)
6.2 APAC Retigabine Sales by Type
6.3 APAC Retigabine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Retigabine by Country
7.1.1 Europe Retigabine Sales by Country (2018-2023)
7.1.2 Europe Retigabine Revenue by Country (2018-2023)
7.2 Europe Retigabine Sales by Type
7.3 Europe Retigabine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Retigabine by Country
8.1.1 Middle East & Africa Retigabine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Retigabine Revenue by Country (2018-2023)
8.2 Middle East & Africa Retigabine Sales by Type
8.3 Middle East & Africa Retigabine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Retigabine
10.3 Manufacturing Process Analysis of Retigabine
10.4 Industry Chain Structure of Retigabine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Retigabine Distributors
11.3 Retigabine Customer
12 World Forecast Review for Retigabine by Geographic Region
12.1 Global Retigabine Market Size Forecast by Region
12.1.1 Global Retigabine Forecast by Region (2024-2029)
12.1.2 Global Retigabine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Retigabine Forecast by Type
12.7 Global Retigabine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Retigabine Product Portfolios and Specifications
13.1.3 Merck Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 BioVision
13.2.1 BioVision Company Information
13.2.2 BioVision Retigabine Product Portfolios and Specifications
13.2.3 BioVision Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioVision Main Business Overview
13.2.5 BioVision Latest Developments
13.3 Selleck Chemicals
13.3.1 Selleck Chemicals Company Information
13.3.2 Selleck Chemicals Retigabine Product Portfolios and Specifications
13.3.3 Selleck Chemicals Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Selleck Chemicals Main Business Overview
13.3.5 Selleck Chemicals Latest Developments
13.4 Bio-Techne
13.4.1 Bio-Techne Company Information
13.4.2 Bio-Techne Retigabine Product Portfolios and Specifications
13.4.3 Bio-Techne Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bio-Techne Main Business Overview
13.4.5 Bio-Techne Latest Developments
13.5 Cayman Chemical
13.5.1 Cayman Chemical Company Information
13.5.2 Cayman Chemical Retigabine Product Portfolios and Specifications
13.5.3 Cayman Chemical Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cayman Chemical Main Business Overview
13.5.5 Cayman Chemical Latest Developments
13.6 Adooq Bioscience
13.6.1 Adooq Bioscience Company Information
13.6.2 Adooq Bioscience Retigabine Product Portfolios and Specifications
13.6.3 Adooq Bioscience Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adooq Bioscience Main Business Overview
13.6.5 Adooq Bioscience Latest Developments
13.7 Alomone Labs
13.7.1 Alomone Labs Company Information
13.7.2 Alomone Labs Retigabine Product Portfolios and Specifications
13.7.3 Alomone Labs Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Alomone Labs Main Business Overview
13.7.5 Alomone Labs Latest Developments
13.8 Toronto Research Chemicals
13.8.1 Toronto Research Chemicals Company Information
13.8.2 Toronto Research Chemicals Retigabine Product Portfolios and Specifications
13.8.3 Toronto Research Chemicals Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Toronto Research Chemicals Main Business Overview
13.8.5 Toronto Research Chemicals Latest Developments
13.9 BOCSCI
13.9.1 BOCSCI Company Information
13.9.2 BOCSCI Retigabine Product Portfolios and Specifications
13.9.3 BOCSCI Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BOCSCI Main Business Overview
13.9.5 BOCSCI Latest Developments
13.10 Biosynth Carbosynth
13.10.1 Biosynth Carbosynth Company Information
13.10.2 Biosynth Carbosynth Retigabine Product Portfolios and Specifications
13.10.3 Biosynth Carbosynth Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biosynth Carbosynth Main Business Overview
13.10.5 Biosynth Carbosynth Latest Developments
13.11 Axon Biochemicals BV
13.11.1 Axon Biochemicals BV Company Information
13.11.2 Axon Biochemicals BV Retigabine Product Portfolios and Specifications
13.11.3 Axon Biochemicals BV Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Axon Biochemicals BV Main Business Overview
13.11.5 Axon Biochemicals BV Latest Developments
13.12 Beyotime
13.12.1 Beyotime Company Information
13.12.2 Beyotime Retigabine Product Portfolios and Specifications
13.12.3 Beyotime Retigabine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beyotime Main Business Overview
13.12.5 Beyotime Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Retigabine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Retigabine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Retigabine Sales by Type (2018-2023) & (Kg)
Table 7. Global Retigabine Sales Market Share by Type (2018-2023)
Table 8. Global Retigabine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Retigabine Revenue Market Share by Type (2018-2023)
Table 10. Global Retigabine Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Retigabine Sales by Application (2018-2023) & (Kg)
Table 12. Global Retigabine Sales Market Share by Application (2018-2023)
Table 13. Global Retigabine Revenue by Application (2018-2023)
Table 14. Global Retigabine Revenue Market Share by Application (2018-2023)
Table 15. Global Retigabine Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Retigabine Sales by Company (2018-2023) & (Kg)
Table 17. Global Retigabine Sales Market Share by Company (2018-2023)
Table 18. Global Retigabine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Retigabine Revenue Market Share by Company (2018-2023)
Table 20. Global Retigabine Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Retigabine Producing Area Distribution and Sales Area
Table 22. Players Retigabine Products Offered
Table 23. Retigabine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Retigabine Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Retigabine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Retigabine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Retigabine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Retigabine Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Retigabine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Retigabine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Retigabine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Retigabine Sales by Country (2018-2023) & (Kg)
Table 35. Americas Retigabine Sales Market Share by Country (2018-2023)
Table 36. Americas Retigabine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Retigabine Revenue Market Share by Country (2018-2023)
Table 38. Americas Retigabine Sales by Type (2018-2023) & (Kg)
Table 39. Americas Retigabine Sales by Application (2018-2023) & (Kg)
Table 40. APAC Retigabine Sales by Region (2018-2023) & (Kg)
Table 41. APAC Retigabine Sales Market Share by Region (2018-2023)
Table 42. APAC Retigabine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Retigabine Revenue Market Share by Region (2018-2023)
Table 44. APAC Retigabine Sales by Type (2018-2023) & (Kg)
Table 45. APAC Retigabine Sales by Application (2018-2023) & (Kg)
Table 46. Europe Retigabine Sales by Country (2018-2023) & (Kg)
Table 47. Europe Retigabine Sales Market Share by Country (2018-2023)
Table 48. Europe Retigabine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Retigabine Revenue Market Share by Country (2018-2023)
Table 50. Europe Retigabine Sales by Type (2018-2023) & (Kg)
Table 51. Europe Retigabine Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Retigabine Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Retigabine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Retigabine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Retigabine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Retigabine Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Retigabine Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Retigabine
Table 59. Key Market Challenges & Risks of Retigabine
Table 60. Key Industry Trends of Retigabine
Table 61. Retigabine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Retigabine Distributors List
Table 64. Retigabine Customer List
Table 65. Global Retigabine Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Retigabine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Retigabine Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Retigabine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Retigabine Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Retigabine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Retigabine Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Retigabine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Retigabine Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Retigabine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Retigabine Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Retigabine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Retigabine Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Retigabine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Retigabine Product Portfolios and Specifications
Table 81. Merck Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. BioVision Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 85. BioVision Retigabine Product Portfolios and Specifications
Table 86. BioVision Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. BioVision Main Business
Table 88. BioVision Latest Developments
Table 89. Selleck Chemicals Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 90. Selleck Chemicals Retigabine Product Portfolios and Specifications
Table 91. Selleck Chemicals Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. Selleck Chemicals Main Business
Table 93. Selleck Chemicals Latest Developments
Table 94. Bio-Techne Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 95. Bio-Techne Retigabine Product Portfolios and Specifications
Table 96. Bio-Techne Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Bio-Techne Main Business
Table 98. Bio-Techne Latest Developments
Table 99. Cayman Chemical Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 100. Cayman Chemical Retigabine Product Portfolios and Specifications
Table 101. Cayman Chemical Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. Cayman Chemical Main Business
Table 103. Cayman Chemical Latest Developments
Table 104. Adooq Bioscience Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 105. Adooq Bioscience Retigabine Product Portfolios and Specifications
Table 106. Adooq Bioscience Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Adooq Bioscience Main Business
Table 108. Adooq Bioscience Latest Developments
Table 109. Alomone Labs Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 110. Alomone Labs Retigabine Product Portfolios and Specifications
Table 111. Alomone Labs Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. Alomone Labs Main Business
Table 113. Alomone Labs Latest Developments
Table 114. Toronto Research Chemicals Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 115. Toronto Research Chemicals Retigabine Product Portfolios and Specifications
Table 116. Toronto Research Chemicals Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. Toronto Research Chemicals Main Business
Table 118. Toronto Research Chemicals Latest Developments
Table 119. BOCSCI Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 120. BOCSCI Retigabine Product Portfolios and Specifications
Table 121. BOCSCI Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. BOCSCI Main Business
Table 123. BOCSCI Latest Developments
Table 124. Biosynth Carbosynth Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 125. Biosynth Carbosynth Retigabine Product Portfolios and Specifications
Table 126. Biosynth Carbosynth Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Biosynth Carbosynth Main Business
Table 128. Biosynth Carbosynth Latest Developments
Table 129. Axon Biochemicals BV Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 130. Axon Biochemicals BV Retigabine Product Portfolios and Specifications
Table 131. Axon Biochemicals BV Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. Axon Biochemicals BV Main Business
Table 133. Axon Biochemicals BV Latest Developments
Table 134. Beyotime Basic Information, Retigabine Manufacturing Base, Sales Area and Its Competitors
Table 135. Beyotime Retigabine Product Portfolios and Specifications
Table 136. Beyotime Retigabine Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 137. Beyotime Main Business
Table 138. Beyotime Latest Developments
List of Figures
Figure 1. Picture of Retigabine
Figure 2. Retigabine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Retigabine Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Retigabine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Retigabine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Retigabine Sales Market Share by Type in 2022
Figure 13. Global Retigabine Revenue Market Share by Type (2018-2023)
Figure 14. Retigabine Consumed in Research
Figure 15. Global Retigabine Market: Research (2018-2023) & (Kg)
Figure 16. Retigabine Consumed in Medical
Figure 17. Global Retigabine Market: Medical (2018-2023) & (Kg)
Figure 18. Global Retigabine Sales Market Share by Application (2022)
Figure 19. Global Retigabine Revenue Market Share by Application in 2022
Figure 20. Retigabine Sales Market by Company in 2022 (Kg)
Figure 21. Global Retigabine Sales Market Share by Company in 2022
Figure 22. Retigabine Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Retigabine Revenue Market Share by Company in 2022
Figure 24. Global Retigabine Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Retigabine Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Retigabine Sales 2018-2023 (Kg)
Figure 27. Americas Retigabine Revenue 2018-2023 ($ Millions)
Figure 28. APAC Retigabine Sales 2018-2023 (Kg)
Figure 29. APAC Retigabine Revenue 2018-2023 ($ Millions)
Figure 30. Europe Retigabine Sales 2018-2023 (Kg)
Figure 31. Europe Retigabine Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Retigabine Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Retigabine Revenue 2018-2023 ($ Millions)
Figure 34. Americas Retigabine Sales Market Share by Country in 2022
Figure 35. Americas Retigabine Revenue Market Share by Country in 2022
Figure 36. Americas Retigabine Sales Market Share by Type (2018-2023)
Figure 37. Americas Retigabine Sales Market Share by Application (2018-2023)
Figure 38. United States Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Retigabine Sales Market Share by Region in 2022
Figure 43. APAC Retigabine Revenue Market Share by Regions in 2022
Figure 44. APAC Retigabine Sales Market Share by Type (2018-2023)
Figure 45. APAC Retigabine Sales Market Share by Application (2018-2023)
Figure 46. China Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Retigabine Sales Market Share by Country in 2022
Figure 54. Europe Retigabine Revenue Market Share by Country in 2022
Figure 55. Europe Retigabine Sales Market Share by Type (2018-2023)
Figure 56. Europe Retigabine Sales Market Share by Application (2018-2023)
Figure 57. Germany Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Retigabine Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Retigabine Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Retigabine Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Retigabine Sales Market Share by Application (2018-2023)
Figure 66. Egypt Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Retigabine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Retigabine in 2022
Figure 72. Manufacturing Process Analysis of Retigabine
Figure 73. Industry Chain Structure of Retigabine
Figure 74. Channels of Distribution
Figure 75. Global Retigabine Sales Market Forecast by Region (2024-2029)
Figure 76. Global Retigabine Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Retigabine Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Retigabine Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Retigabine Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Retigabine Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレチガビン市場予測 2023年-2029年(Global Retigabine Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のレチガビン市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp